EichorEICHOR
Condition: Respiratory Syncytial Viruses Synced from ClinicalTrials.gov · August 07, 2026

Recruiting studies: Respiratory Syncytial Viruses

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Characterize the Safety and Immunogenicity of AZD6489 in Participants 60 Years of Age and Older (ARIES)
Phase 1/Phase 2 · 6 location(s) · AstraZeneca · NCT07717840PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Viru
Phase 2 · 12 location(s) · Pulmotect, Inc. · NCT06665100A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Sin
Phase 3 · 97 location(s) · Pfizer · NCT06866405Real-World Effectiveness of Perinatal RSV Immunoprophylaxis
Phase N/A · 1 location(s) · Yale University · NCT06172660Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children With Lower Respiratory Tract In
Phase 3 · 1 location(s) · Kexing Biopharm Co., Ltd. · NCT06363370Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18
Phase 1 · 6 location(s) · Sanofi · NCT07516418RSV Vaccination in Immunocompromised Patients.
Phase 2 · 1 location(s) · Medical University of Vienna · NCT06597916Clinical Trial of Recombinant RSV Vaccine (CHO Cell) (Adjuvanted) in Chinese Population Aged 18 Years and Older.
Phase 1/Phase 2 · 1 location(s) · Ab&B Bio-tech Co., Ltd.JS · NCT07582796RSV Vaccine Pregnancy Registry
Phase N/A · 1 location(s) · CorEvitas · NCT06521944COVID-19 Impact on RSV Emergency Presentations
Phase N/A · 1 location(s) · University Hospitals, Leicester · NCT04959734A Clinical Trial of SIBP-A16 Injection in Healthy Adults
EARLY_Phase 1 · 1 location(s) · Shanghai Institute Of Biological Products · NCT07106918Virological Surveillance of Acute Respiratory Infection in Primary Health Care in Metropolitan France
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT07599449Association of Dysbiosis and Immune Response in Bronchiolitis in Under 12 Months -Old Infants
Phase N/A · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06161285In-depth Analysis of the Immune Responses in the Upper Respiratory Tract in Older Adults Infected or Colonized With Stre
Phase N/A · 1 location(s) · University Hospital, Geneva · NCT06998251A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age
Phase 2 · 8 location(s) · Enanta Pharmaceuticals, Inc · NCT07482657Assessing Antiviral Treatments in Early Symptomatic RSV
Phase 2 · 2 location(s) · University of Oxford · NCT06488300Immunogenicity of RSVPreF3 Vaccine in Immunocompromised Persons
Phase 2 · 1 location(s) · Johns Hopkins University · NCT07050732Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years
Phase 1/Phase 2 · 17 location(s) · Sanofi · NCT07734649A Study of Ziresovir (AK0529) in High-risk Adult With Respiratory Syncytial Virus (RSV) Infection.
Phase 2/Phase 3 · 9 location(s) · Shanghai Ark Biopharmaceutical Co., Ltd. · NCT07658534Safety, Pharmacokinetics, and Antiviral Activity of Remdesivir (VEKLURY®) in Hospitalized Children With RSV
Phase 2 · 8 location(s) · PENTA Foundation · NCT06873633A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of
Phase 2 · 83 location(s) · Shionogi · NCT07214571Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination
Phase 3 · 1 location(s) · Centre Hospitalier Annecy Genevois · NCT07232706Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell)
Phase 3 · 8 location(s) · MAXVAX Biotechnology Limited Liability Company · NCT07272434Identification and Clinical Validation of Biomarkers Associated With Clinical Severity in Adults Infected With RSV
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06197152RSV Immunogenicity Study in the Elderly (RISE)
Phase 3 · 2 location(s) · Karin Karin Loré · NCT07203365Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06881953Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
Phase 3 · 15 location(s) · University of Alabama at Birmingham · NCT05026749Genotype and Disease Burden of RSV in Older Vietnamese Adults (RSV: Respiratory Syncytial Virus )
Phase N/A · 1 location(s) · Tam Anh Research Institute · NCT07239583Antibiotic Therapy in Viral Airway Infections
Phase 4 · 12 location(s) · University Hospital, Akershus · NCT05045612Safety of RSV Preventive Monoclonal Antibody
Phase 4 · 6 location(s) · Duke University · NCT07158814
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.